JOURNAL
Current Issue
Journal Archive
.............................................................
July 2021 -
Volume 19, Issue 7


View this issue in pdf format

........................................................
From the Editor

........................................................

 

Reject rate analysis in radiography in Primary health care corporation, Qatar
Tamer F. Ali, Mona A. M. Mohammed
[pdf]
[Abstract]
DOI: 10.5742/MEWFM.2021.94073

Hip replacement in sickle cell anemia patient and the effect of Musculoskeletal changes other than hip joint on outcome
Mohammed Lafi Al-Otaibi
[pdf]
[Abstract]
DOI: 10.5742/MEWFM.2021.94074

Risk Factors of Diabetic Ketoacidosis among Type 1 Diabetic Patients in Abha City, Saudi Arabia
Youssef H. Al Zahib, Saleh A. Alshaikhi, Ayoub A. Alshaikh, Mohammed H. Al Zahib, Hassan MH Alshehri, Saad A. Alamri, Ayedh AA Alahmari

[pdf]
[Abstract]
DOI: 10.5742/MEWFM.2021.94075

Assessment of Knowledge of Physicians and their Practices in Managing Asymptomatic Hyperuricemia at Primary Health centers in Bisha Province, Saudi Arabia
Muffarah Hamid Alharthi
[pdf]
[Abstract]

DOI: 10.5742/MEWFM.2021.94085

Covid 19 in the Region

Lifestyle changes that can increase the risk of cardiovascular disease during the COVID-19 pandemic: a cross-sectional study
Mohammed A Alrubaysh, Abdullah A Alkahtani, Ziyad S Alluwaymi, Samar M Alanazi, Amal M Alanazi, Khalid M Al Harbi
[pdf]
[Abstract]
DOI: 10.5742/MEWFM.2021.94076

Development patterns of olfactory disorders in Covid-19 patients, Aden, Yemen
Saleh Mohamed Abobaker Alshaiby
[pdf]
[Abstract]
DOI: 10.5742/MEWFM.2021.94077

Population and Community Studies

Functional constipation and its association with lifestyle habits of medical students using Rome IV Diagnostic Criteria
Jawairia Ilyas, Shahnoor Shahid, Aliya Jafri, Munazza Saeed, Asra Rizwan, Ushna Khan, Saniya M Zahir
[pdf]
[Abstract]
DOI: 10.5742/MEWFM.2021.94078

Alopecia areata: characteristics and associated diseases among patients in Aden, Yemen
Asia Hassan Abdulla Saleh, Amer Omer Abdullah Bin Alzou
[pdf]
[Abstract]
DOI: 10.5742/MEWFM.2021.94079


Knowledge, Attitudes and Practice toward Testicular Cancer and Testicular Self-Examination among adolescents and young adults in Aseer region, Saudi Arabia
Abdulaziz Alamri, Yahya Mohammed Alqahtani, Mohammed Mushabab Al-Mudhi
Bander Bin Saleh A. Alsalmy Asiri, Khalid Abdullah Alasmari, Shehata Farag Shehata, Raed Almannie
[pdf]
[Abstract]
DOI: 10.5742/MEWFM.2021.94082

Reviews

Why are SGLT2 inhibitors a good choice in the management of Type 2 Diabetes Mellitus?
Nhila Ghazanfar
[pdf]
[Abstract]

DOI: 10.5742/MEWFM.2021.94080

Degeneration of a fibroid:
A challenging diagnosis - Case report

Nhila Ghazanfar, Lamia Zafrani
[pdf]
[Abstract]
DOI: 10.5742/MEWFM.2021.94081

Pituitary dysfunction following a traumatic brain injury (TBI) at the desk of a General Practitioner
Almoutaz Alkhier Ahmed, Nada Najb Almulla, Manal Ali Ahli, Aisha Abdelrahman Alzarouni
[pdf]
[Abstract]

DOI: 10.5742/MEWFM.2021.94083

COVID-19 Mass Vaccination
Hamda A.Alqaatri
[pdf]
[Abstract]
DOI: 10.5742/MEWFM.2021.94084

Regional Thesis

Communication Challenges Between the Primary Health Care Command Center and Nodal Health Centers During Disasters in Qatar
Hamda Ahmed J H AlQaatri
[pdf]
[Abstract]
DOI: 10.5742/MEWFM.2021.94088

Middle East Quality Improvement Program
(MEQUIP QI&CPD)


Chief Editor -
Abdulrazak Abyad MD, MPH, MBA, AGSF, AFCHSE

.........................................................

Publisher -
Lesley Pocock
medi+WORLD International
AUSTRALIA
Email
: lesleypocock@mediworld.com.au
.........................................................

Editorial Enquiries -
abyad@cyberia.net.lb
.........................................................

Advertising Enquiries -
lesleypocock@mediworld.com.au
.........................................................

While all efforts have been made to ensure the accuracy of the information in this journal, opinions expressed are those of the authors and do not necessarily reflect the views of The Publishers, Editor or the Editorial Board. The publishers, Editor and Editorial Board cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; or the views and opinions expressed. Publication of any advertisements does not constitute any endorsement by the Publishers and Editors of the product advertised.

The contents of this journal are copyright. Apart from any fair dealing for purposes of private study, research, criticism or review, as permitted under the Australian Copyright Act, no part of this program may be reproduced without the permission of the publisher.







   
July 2021 - Volume 19, Issue 7

Why are SGLT2 inhibitors a good choice in the management of Type 2 Diabetes Mellitus?

General Practitioner -PHCC- Doha Qatar. MBChB, MRCGP.

Correspondence:
Dr Nhila Ghazanfar, General Practitioner PHCC,
Doha, Qatar. .
Email: gnhila@gmail.com

Received: May 2021; Accepted: June 2021; Published: July 1, 2021. Citation: Nhila Ghazanfar. Why are SGLT2 inhibitors a good choice in the management of Type 2 Diabetes Mellitus? World Family Medicine. 2021; 19(7): 86-88 DOI: 10.5742/MEWFM.2021.94080

Abstract


Sodium-glucose co-transporter 2 inhibitors (SGLT2) are the most recent addition to the oral management of type 2 diabetes mellitus. This chronic progressive disease is linked to cardiovascular and renal disease causing millions of deaths each year worldwide. As oral treatment options have expanded over the years, this has made the management of diabetes mellitus more tailored to individuals taking into account their co-existing comorbidities and therefore slightly more challenging.

Several benefits have been reported from SGLT2 including their ability to improve plasma glucose levels, lower blood pressure, weight loss and more importantly their cardiovascular and renal beneficial outcomes making them one of the popular choices for add on to monotherapy in current guidelines.

This article looks at why SGLT are likely to be considered sooner for initiation of the management of diabetes compared to other available medication.

Key words: Sodium-glucose co-transporter 2 inhibitors (SGLT2); management Type 2 diabetes







 


 

.................................................................................................................